EMA Updates Guidelines on Excipients in Labeling
On October 9, 2017, the European Medicines Agency (EMA) announced that the annex to the guideline on excipients in labeling and packaging of drug products has been updated to include all excipients that must be listed in the labeling and packaging leaflets of drugs and their safety warnings.
The guideline was updated to take into consideration safety concerns not currently addressed in the existing annex, with specific attention to excipients that may affect children or pregnant women. Five new excipients are included, and 10 have been updated with new safety warnings.
Source: EMA
|
|---|
|
Columnists
Webcasts
Outsourcing
FDA Approves Drug Product Manufacturing for Samsung BioLogics
Drug product approval from FDA follows previous approvals from European and Japanese authorities.
CMO Roundup: Expansions for Biomanufacturing
CMOs have been active over the past year in expanding their biologics production and capabilities.
Outsourcing Glycan Analysis
Industry experts discuss the challenges of performing glycan analysis and how companies can gain specific expertise from outsourcing partners.
Sponsored Links
